byiShook Opinion
Aug 13, 2024 - 15:25
Baxter stock tumbled Tuesday after the medtech company agreed to sell its kidney segment to Carlyle for $3.8 billion. The post Baxter Tumbles On $3.8 Billion Kidney Deal — Why Investors Expected More appeared first on Investor's Business Daily.
Baxter stock tumbled Tuesday after the medtech company agreed to sell its kidney segment to Carlyle for $3.8 billion.
The post Baxter Tumbles On $3.8 Billion Kidney Deal â Why Investors Expected More appeared first on Investor's Business Daily.